Copyright Reports & Markets. All rights reserved.

Global Chronic Kidney Disease Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 ACE Inhibitors
      • 1.4.3 Calcium Channel Blockers
      • 1.4.4 Beta Blockers
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Chronic Kidney Disease Drugs Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Specialty Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Chronic Kidney Disease Drugs Market Size
    • 2.2 Chronic Kidney Disease Drugs Growth Trends by Regions
      • 2.2.1 Chronic Kidney Disease Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Chronic Kidney Disease Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Chronic Kidney Disease Drugs Market Size by Manufacturers
      • 3.1.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chronic Kidney Disease Drugs Key Players Head office and Area Served
    • 3.3 Key Players Chronic Kidney Disease Drugs Product/Solution/Service
    • 3.4 Date of Enter into Chronic Kidney Disease Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Chronic Kidney Disease Drugs Market Size by Type (2014-2019)
    • 4.2 Global Chronic Kidney Disease Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 5.2 Chronic Kidney Disease Drugs Key Players in United States
    • 5.3 United States Chronic Kidney Disease Drugs Market Size by Type
    • 5.4 United States Chronic Kidney Disease Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 6.2 Chronic Kidney Disease Drugs Key Players in Europe
    • 6.3 Europe Chronic Kidney Disease Drugs Market Size by Type
    • 6.4 Europe Chronic Kidney Disease Drugs Market Size by Application

    7 China

    • 7.1 China Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 7.2 Chronic Kidney Disease Drugs Key Players in China
    • 7.3 China Chronic Kidney Disease Drugs Market Size by Type
    • 7.4 China Chronic Kidney Disease Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 8.2 Chronic Kidney Disease Drugs Key Players in Japan
    • 8.3 Japan Chronic Kidney Disease Drugs Market Size by Type
    • 8.4 Japan Chronic Kidney Disease Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 9.2 Chronic Kidney Disease Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Chronic Kidney Disease Drugs Market Size by Type
    • 9.4 Southeast Asia Chronic Kidney Disease Drugs Market Size by Application

    10 India

    • 10.1 India Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 10.2 Chronic Kidney Disease Drugs Key Players in India
    • 10.3 India Chronic Kidney Disease Drugs Market Size by Type
    • 10.4 India Chronic Kidney Disease Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Chronic Kidney Disease Drugs Market Size (2014-2019)
    • 11.2 Chronic Kidney Disease Drugs Key Players in Central & South America
    • 11.3 Central & South America Chronic Kidney Disease Drugs Market Size by Type
    • 11.4 Central & South America Chronic Kidney Disease Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Keryx Biopharmaceuticals, Inc
      • 12.1.1 Keryx Biopharmaceuticals, Inc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Chronic Kidney Disease Drugs Introduction
      • 12.1.4 Keryx Biopharmaceuticals, Inc Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.1.5 Keryx Biopharmaceuticals, Inc Recent Development
    • 12.2 Kissei Pharmaceutical Co., Ltd
      • 12.2.1 Kissei Pharmaceutical Co., Ltd Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Chronic Kidney Disease Drugs Introduction
      • 12.2.4 Kissei Pharmaceutical Co., Ltd Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
    • 12.3 AbbVie
      • 12.3.1 AbbVie Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Chronic Kidney Disease Drugs Introduction
      • 12.3.4 AbbVie Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.3.5 AbbVie Recent Development
    • 12.4 GlaxoSmithKline
      • 12.4.1 GlaxoSmithKline Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Chronic Kidney Disease Drugs Introduction
      • 12.4.4 GlaxoSmithKline Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.4.5 GlaxoSmithKline Recent Development
    • 12.5 Sanofi
      • 12.5.1 Sanofi Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Chronic Kidney Disease Drugs Introduction
      • 12.5.4 Sanofi Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.5.5 Sanofi Recent Development
    • 12.6 F. Hoffmann-La Roche Ltd
      • 12.6.1 F. Hoffmann-La Roche Ltd Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Chronic Kidney Disease Drugs Introduction
      • 12.6.4 F. Hoffmann-La Roche Ltd Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.6.5 F. Hoffmann-La Roche Ltd Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Chronic Kidney Disease Drugs Introduction
      • 12.7.4 Pfizer Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.7.5 Pfizer Recent Development
    • 12.8 AstraZeneca
      • 12.8.1 AstraZeneca Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Chronic Kidney Disease Drugs Introduction
      • 12.8.4 AstraZeneca Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.8.5 AstraZeneca Recent Development
    • 12.9 Amgen
      • 12.9.1 Amgen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Chronic Kidney Disease Drugs Introduction
      • 12.9.4 Amgen Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.9.5 Amgen Recent Development
    • 12.10 Teva Pharmaceutical Industries
      • 12.10.1 Teva Pharmaceutical Industries Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Chronic Kidney Disease Drugs Introduction
      • 12.10.4 Teva Pharmaceutical Industries Revenue in Chronic Kidney Disease Drugs Business (2014-2019)
      • 12.10.5 Teva Pharmaceutical Industries Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Chronic Kidney Disease Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Chronic Kidney Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Kidney Disease Drugs development in United States, Europe and China.

      The key players covered in this study
      Keryx Biopharmaceuticals, Inc
      Kissei Pharmaceutical Co., Ltd
      AbbVie
      GlaxoSmithKline
      Sanofi
      F. Hoffmann-La Roche Ltd
      Pfizer
      AstraZeneca
      Amgen
      Teva Pharmaceutical Industries

      Market segment by Type, the product can be split into
      ACE Inhibitors
      Calcium Channel Blockers
      Beta Blockers
      Others

      Market segment by Application, split into
      Hospitals
      Specialty Clinics

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Chronic Kidney Disease Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Chronic Kidney Disease Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Chronic Kidney Disease Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now